Back to search
FDAFDA · Food and drugs·Recall number Z-0415-2020

Guardia Access Nano Embryo Transfer Catheter is use for transferring IVF embryos into the uterine cavity.

Published November 27, 2019 · Recall initiated: October 3, 2019

Summary

FDA records medical device Class II recall Z-0415-2020, published November 27, 2019 and initiated October 3, 2019. Recalling firm: Cook Inc.; Status: Terminated; Reported quantity: 202; Lot: Lot Number 9502915. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Bent transfer catheter tips may cause difficulty or inability in inserting the transfer catheter into the guiding catheter. Potential adverse events that may occur if an affected product is used include increased procedural time, the need for a repeat embryo transfer procedure, or the need for a patient to undergo an additional IVF cycle.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cook Inc.
Distributor
No US distribution. The products were distributed to the following foreign countries: Belgium, Denmark, Germany, Italy, Netherlands, Norway, Poland, Republic of Macedonia, Slovenia, Spain, and Switzerland.
Lot
Lot Number 9502915
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Guardia Access Nano Embryo Transfer Catheter is use for transferring IVF embryos into the uterine cavity. recalled?

Yes. FDA published recall Z-0415-2020 on November 27, 2019. Reported hazard: Bent transfer catheter tips may cause difficulty or inability in inserting the transfer catheter into the guiding catheter. Potential adverse events that may occur if an affected product is used include increased procedural time, the need for a repeat embryo transfer procedure, or the need for a patient to undergo an additional IVF cycle.

What should I do if I have this product?

Voluntary: Firm initiated · Letter